Jackowski; George

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jackowski; George.The latest application filed is for "polyclonal-monoclonal elisa assay for detecting n-terminus pro-bnp".

Company Profile

8.75.138

Jackowski; George - Kettleby CA
Jackowski; George - King Township CA
JACKOWSKI; George - King CA
Jackowski; George - Kettleby Ontario CA
Jackowski; George - Kettelby CA
Jackowski; George - Inglewood CA
Jackowski; George - Halton Hills CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Polyclonal-monoclonal Elisa Assay For Detecting N-terminus Pro-bnp App 20220099687 - Davey; Michelle ; et al.	2022-03-31
Nanoformulations Containing Encapsulted Omega-3 Fatty Acids App 20210153534 - MacSweeney; Rachelle ; et al.	2021-05-27
Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP Grant 11,016,106 - Davey , et al. May 25, 2	2021-05-25
Nanoformulations containing encapsulted omega-3 fatty acids Grant 10,912,326 - MacSweeney , et al. February 9, 2	2021-02-09
Nanoformulations Containing Encapsulted Omega-3 Fatty Acids App 20200060321 - MacSweeney; Rachelle ; et al.	2020-02-27
Polyclonal-monoclonal Elisa Assay For Detecting N-terminus Pro-bnp App 20170010288 - Davey; Michelle ; et al.	2017-01-12
Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP Grant 9,371,382 - Davey , et al. June 21, 2	2016-06-21
Process And Composition For Stabilization Of Vulnerable Plaque Utilizing A Combination Of A Statin And Omega 3 Fatty Acids App 20160128967 - JACKOWSKI; George ; et al.	2016-05-12
Process and composition for stabilization of vulnerable plaque utilizing a combination of a statin and omega 3 fatty acids Grant 9,248,138 - Jackowski , et al. February 2, 2	2016-02-02
Method For Treating Obesity With Anti-obesity Formulations And Omega 3 Fatty Acids For The Reduction Of Body Weight In Cardiovascular Disease Patients (cvd) And Diabetics App 20150272920 - JACKOWSKI; George ; et al.	2015-10-01
Omega 3 Fatty Acid For Use As A Prescription Medical Food And Omega 3 Fatty Acid Diagnostic Assay For The Dietary Management Of Cardiovascular Patients With Cardiovascular Disease (cvd) Who Are Deficient In Blood Epa And Dha Levels App 20150246012 - JACKOWSKI; George ; et al.	2015-09-03
Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels Grant 9,119,826 - Jackowski , et al. September 1, 2	2015-09-01
Omega 3 Formulations For Treatment Of Risk Factors For Cardiovascular Disease And Protection Against Sudden Death App 20150224075 - JACKOWSKI; George ; et al.	2015-08-13
Process And Composition For Stabilization Of Vulnerable Plaque Utilizing A Combination Of A Statin And Omega 3 Fatty Acids App 20150196571 - JACKOWSKI; George ; et al.	2015-07-16
Statin And Omega 3 Fatty Acids For Reduction Of Apolipoprotein-b Levels App 20150119414 - JACKOWSKI; George ; et al.	2015-04-30
Cholesterol Absorption Inhibitor And Omega 3 Fatty Acids For The Reduction Of Cholesterol And For The Prevention Or Reduction Of Cardiovascular, Cardiac And Vascular Events App 20150119368 - JACKOWSKI; George ; et al.	2015-04-30
Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events Grant 8,952,000 - Jackowski , et al. February 10, 2	2015-02-10
Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels Grant 8,951,514 - Jackowski , et al. February 10, 2	2015-02-10
Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics Grant 8,715,648 - Jackowski , et al. May 6, 2	2014-05-06
Statin And Omega 3 Fatty Acids For Reduction Of Apolipoprotein-b Levels App 20130079310 - JACKOWSKI; George ; et al.	2013-03-28
Omega 3 Fatty Acidfor Use As A Prescription Medical Food And Omega 3 Fatty Acid Diagniostic Assay For The Dietary Management Of Cardiovascular Patients With Cardiovascular Disease (cvd) Who Are Deficient In Blood Epa And Dha Levels App 20130040913 - JACKOWSKI; George ; et al.	2013-02-14
Cholesterol Absorption Inhibitor And Omega 3 Fatty Acids For The Reduction Of Cholesterol And For The Prevention Or Reduction Of Cardiovascular, Cardiac And Vascular Events App 20130040927 - JACKOWSKI; George ; et al.	2013-02-14
Method For Treating Obesity With Anti-obesity Formulations And Omega 3 Fatty Acids For The Reduction Of Body Weight In Cardiovascular Disease Patients (cvd) And Diabetics App 20130034535 - JACKOWSKI; George ; et al.	2013-02-07
Omega 3 Formulations For Treatment Of Risk Factors For Cardiovascular Disease And Protection Against Sudden Death App 20120302639 - JACKOWSKI; George ; et al.	2012-11-29
Diagnostic methods for congestive heart failure Grant 8,263,351 - Jackowski , et al. September 11, 2	2012-09-11
Methods For Predicting Outcome In Traumatic Brain Injury App 20120149042 - JACKOWSKI; George ; et al.	2012-06-14
Polyclonal-monoclonal Elisa Assay For Detecting N-terminus Pro-bnp App 20120107848 - DAVEY; Michelle ; et al.	2012-05-03
Diagnostic Methods For Congestive Heart Failure App 20110183436 - Jackowski; George ; et al.	2011-07-28
Method for diagnosing and distinguishing stroke and diagnostic devices for use therein Grant 7,955,811 - Jackowski June 7, 2	2011-06-07
Methods For Predicting Outcome In Traumatic Brain Injury App 20100248275 - JACKOWSKI; GEORGE ; et al.	2010-09-30
Calibrator for NT-proBNP immunoassay Grant 7,767,419 - Alvi , et al. August 3, 2	2010-08-03
Method For Diagnosing And Distinguishing Stroke And Diagnostic Devices For Use Therein App 20100136593 - Jackowski; George	2010-06-03
Method for diagnosing and distinguishing stroke and diagnostic devices for use therein Grant 7,655,424 - Jackowski February 2, 2	2010-02-02
Polyclonal-monoclonal Elisa Assay For Detecting N-terminus Pro-bnp App 20090325195 - Davey; Michelle ; et al.	2009-12-31
Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP Grant 7,527,939 - Davey , et al. May 5, 2	2009-05-05
Glycoprotein and apolipoprotein biopolymer markers predictive of Alzheimers disease App 20090093000 - Jackowski; George ; et al.	2009-04-09
Diagnostic methods for congestive heart failure App 20090068676 - Jackowski; George ; et al.	2009-03-12
Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients Grant 7,374,950 - Kang , et al. May 20, 2	2008-05-20
Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons App 20080096286 - Jackowski; George ; et al.	2008-04-24
Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance Grant 7,329,501 - Jackowski , et al. February 12, 2	2008-02-12
Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons Grant 7,314,717 - Jackowski , et al. January 1, 2	2008-01-01
Apolipoprotein biopolymer markers indicative of insulin resistance Grant 7,314,762 - Jackowski , et al. January 1, 2	2008-01-01
Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons Grant 7,294,688 - Jackowski , et al. November 13, 2	2007-11-13
Conjunctive analysis of biological marker expression for predicting cardiac mortality Grant RE39,816 - Stanton , et al. September 4, 2	2007-09-04
Apolipoprotein Biopolymer Markers Indicative Of Insulin Resistance App 20070190666 - Jackowski; George ; et al.	2007-08-16
Methods for predicting outcome in traumatic brain injury App 20070184507 - Jackowski; George ; et al.	2007-08-09
Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons Grant 7,229,638 - Jackowski , et al. June 12, 2	2007-06-12
Complement C3 precursor biopolymer markers indicative of insulin resistance Grant 7,179,610 - Jackowski , et al. February 20, 2	2007-02-20
IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease Grant 7,179,606 - Jackowski , et al. February 20, 2	2007-02-20
Fibronectin precursor biopolymer markers indicative of alzheimer's disease Grant 7,179,605 - Jackowski , et al. February 20, 2	2007-02-20
Protein biopolymer markers predictive of type II diabetes App 20070031979 - Jackowski; George ; et al.	2007-02-08
Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients App 20070020769 - Kang; Jemo ; et al.	2007-01-25
Apolipoprotein biopolymer marker indicative of normal human App 20070009963 - Jackowski; George ; et al.	2007-01-11
Complement C3 precursor biopolymer markers indicative of insulin resistance App 20070010030 - Jackowski; George ; et al.	2007-01-11
Protein biopolymer markers predictive of insulin resistance App 20070010029 - Jackowski; George ; et al.	2007-01-11
Cene-E biopolymer marker indicative of age matched control App 20070003974 - Jackowski; George ; et al.	2007-01-04
Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons App 20060292703 - Jackowski; George ; et al.	2006-12-28
Complement C3 precursor biopolymer markers predictive of type II diabetes App 20060275831 - Jackowski; George ; et al.	2006-12-07
Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients Grant 7,135,329 - Kang , et al. November 14, 2	2006-11-14
Protein biopolymer markers indicative of insulin resistance Grant 7,135,297 - Jackowski , et al. November 14, 2	2006-11-14
Betaine/GABA transport protein biopolymer marker indicative of insulin resistance Grant 7,132,244 - Jackowski , et al. November 7, 2	2006-11-07
Method and kit for diagnosing myocardial infarction Grant 7,125,726 - Jackowski , et al. October 24, 2	2006-10-24
Protein biopolymer markers predictive of type II diabetes Grant 7,125,678 - Jackowski , et al. October 24, 2	2006-10-24
Biopolymer markers indicative of type II diabetes Grant 7,122,327 - Jackowski , et al. October 17, 2	2006-10-17
Protein biopolymer markers indicative of age matched control App 20060211144 - Jackowski; George ; et al.	2006-09-21
Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance App 20060211146 - Jackowski; George ; et al.	2006-09-21
Protein biopolymer markers predictive of insulin resistance App 20060211141 - Jackowski; George ; et al.	2006-09-21
Protein biopolymer markers indicative of age matched control App 20060211147 - Jackowski; George ; et al.	2006-09-21
Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons App 20060211048 - Jackowski; George ; et al.	2006-09-21
Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance App 20060211142 - Jackowski; George ; et al.	2006-09-21
Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP App 20060211070 - Jackowski; George ; et al.	2006-09-21
Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance App 20060211149 - Jackowski; George ; et al.	2006-09-21
Protein biopolymer markers predictive of insulin resistance App 20060211139 - Jackowski; George ; et al.	2006-09-21
Protein biopolymer markers predictive of insulin resistance App 20060211140 - Jackowski; George ; et al.	2006-09-21
Protein biopolymer markers indicative of age matched control App 20060211148 - Jackowski; George ; et al.	2006-09-21
Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance App 20060211150 - Jackowski; George ; et al.	2006-09-21
Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance App 20060211145 - Jackowski; George ; et al.	2006-09-21
Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance App 20060211143 - Jackowski; George ; et al.	2006-09-21
Protein biopolymer markers predictive of insulin resistance App 20060211138 - Jackowski; George ; et al.	2006-09-21
Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients Grant 7,109,023 - Kang , et al. September 19, 2	2006-09-19
Protein biopolymer markers predictive of insulin resistance App 20060205091 - Jackowski; George ; et al.	2006-09-14
Method for detecting the presence of monomeric brain associated human glutamine synthetase Grant 7,101,680 - Jackowski , et al. September 5, 2	2006-09-05
Protein Biopolymer Markers Indicative Of Insulin Resistance App 20060194339 - Jackowski; George ; et al.	2006-08-31
Complement C3 Precursor Biopolymer Markers Indicative Of Insulin Resistance App 20060194338 - Jackowski; George ; et al.	2006-08-31
Fibronectin Precursor Biopolymer Markers Indicative Of Alzheimer's Disease App 20060194337 - Jackowski; George ; et al.	2006-08-31
Protein Biopolymer Markers Predictive Of Type Ii Diabetes App 20060194340 - Jackowski; George ; et al.	2006-08-31
Complement C3 precursor biopolymer markers predictive of type II diabetes Grant 7,097,989 - Jackowski , et al. August 29, 2	2006-08-29
Fibronectin biopolymer marker indicative of insulin resistance Grant 7,094,549 - Jackowski , et al. August 22, 2	2006-08-22
Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons Grant 7,087,435 - Jackowski , et al. August 8, 2	2006-08-08
Complement C3 Precursor Biopolymer Markers Predictive Of Type Ii Diabetes App 20060160232 - Jackowski; George ; et al.	2006-07-20
Ig Heavy Chain, Ig Kappa, Ig Lambda Biopolymer Markers Predictive Of Alzheimers Disease App 20060160233 - Jackowski; George ; et al.	2006-07-20
Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP App 20060154321 - Davey; Michelle ; et al.	2006-07-13
Protein biopolymer markers indicative of alzheimer's disease Grant 7,074,576 - Jackowski , et al. July 11, 2	2006-07-11
Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairment Grant 7,070,945 - Jackowski , et al. July 4, 2	2006-07-04
Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance App 20060134699 - Jackowski; George ; et al.	2006-06-22
Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance App 20060134700 - Jackowski; George ; et al.	2006-06-22
Method for retarding or precluding Alzheimer's dementia App 20060134108 - Jackowski; George ; et al.	2006-06-22
Protein biopolymer markers predictive of insulin resistance Grant 7,052,849 - Jackowski , et al. May 30, 2	2006-05-30
Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons Grant 7,049,397 - Jackowski , et al. May 23, 2	2006-05-23
Apolipoprotein biopolymer marker indicative of normal human App 20060084112 - Jackowski; George ; et al.	2006-04-20
IG lambda biopolymer markers predictive of Alzheimers disease Grant 7,026,129 - Jackowski , et al. April 11, 2	2006-04-11
Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons App 20060068505 - Jackowski; George ; et al.	2006-03-30
Method for retarding or precluding Alzheimer's dementia Grant 7,014,854 - Jackowski , et al. March 21, 2	2006-03-21
Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance Grant 7,015,004 - Jackowski , et al. March 21, 2	2006-03-21
Fibronectin Biopolymer Marker Indicative Of Insulin Resistance App 20060051877 - Jackowski; George ; et al.	2006-03-09
Methods for predicting outcome in traumatic brain injury App 20060051814 - Jackowski; George ; et al.	2006-03-09
Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons Grant 7,008,800 - Jackowski , et al. March 7, 2	2006-03-07
Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons Grant 6,998,243 - Jackowski , et al. February 14, 2	2006-02-14
Protein biopolymer markers predictive of alzheimer's disease App 20060024761 - Jackowski; George ; et al.	2006-02-02
Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons App 20060024755 - Jackowski; George ; et al.	2006-02-02
Biopolymer marker indicative of disease state having a molecular weight of 1525 daltons App 20060024671 - Jackowski; George ; et al.	2006-02-02
Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP App 20050287613 - Jackowski, George ; et al.	2005-12-29
Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons App 20050287599 - Jackowski, George ; et al.	2005-12-29
Macroglobulin Biopolymer Markers Indicative Of Insulin Resistance App 20050287595 - Jackowski, George ; et al.	2005-12-29
Diagnosis and treatment of early pre-Type-1 diabetes utilizing glial fibrillary acidic protein App 20050214874 - Jackowski, George ; et al.	2005-09-29
Method for diagnosing and distinguishing stroke and diagnostic devices for use therein App 20050136496 - Jackowski, George	2005-06-23
Diagnosis and treatment of early pre-type-1 diabetes utilizing neuronal proteins App 20050130245 - Houle, Jean-Francois ; et al.	2005-06-16
Diagnostic methods for congestive heart failure App 20050100964 - Jackowski, George ; et al.	2005-05-12
Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons Grant 6,890,763 - Jackowski , et al. May 10, 2	2005-05-10
HP biopolymer markers predictive of insulin resistance Grant 6,890,722 - Jackowski , et al. May 10, 2	2005-05-10
Method for identification of glycosylated polypeptides App 20040253659 - Rasamoelisolo, Michele ; et al.	2004-12-16
Biopolymer marker indicative of disease state having a molecular weight of 2056 daltons App 20040224423 - Jackowski, George ; et al.	2004-11-11
Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons App 20040198950 - Jackowski, George ; et al.	2004-10-07
Method for diagnosing and distinguishing stroke and diagnostic devices for use therein Grant 6,780,606 - Jackowski August 24, 2	2004-08-24
Calibrator for NT-proBNP immunoassay App 20040152128 - Alvi, Azhar ; et al.	2004-08-05
Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons Grant 6,756,476 - Jackowski , et al. June 29, 2	2004-06-29
Method of confirming the presence of myocardial infarction App 20040121306 - Kupchak, Peter ; et al.	2004-06-24
Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients App 20040096989 - Kang, Jemo ; et al.	2004-05-20
Polyclonal-monoclonal elisa assay for detecting n-terminus proBNP App 20040096920 - Davey, Michelle ; et al.	2004-05-20
Immunossay Device For Diagnosing Congestive Heart Failure And Predicting Mortality In Congestive Heart Failure Patients App 20040096988 - Kang, Jemo ; et al.	2004-05-20
Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP App 20040096919 - Davey, Michelle ; et al.	2004-05-20
Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons Grant 6,703,366 - Jackowski , et al. March 9, 2	2004-03-09
Method and apparatus for detection of multiple biological materials with a heterogeneous antibody mixture Grant 6,696,264 - Bodenhamer , et al. February 24, 2	2004-02-24
Biopolymer marker indicative of disease state having a molecular weight of 1521 daltons Grant 6,693,080 - Jackowski , et al. February 17, 2	2004-02-17
Surface binding of an immunoglobulin to a flexible polymer using a water soluble varnish matrix Grant 6,692,973 - Bodenhamer , et al. February 17, 2	2004-02-17
Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons Grant 6,677,303 - Jackowski , et al. January 13, 2	2004-01-13
Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons Grant 6,627,607 - Jackowski , et al. September 30, 2	2003-09-30
Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons Grant 6,627,606 - Jackowski , et al. September 30, 2	2003-09-30
Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons Grant 6,627,608 - Jackowski , et al. September 30, 2	2003-09-30
Biopolymer marker indicative of disease state having molecular weight of 2937 daltons Grant 6,620,786 - Jackowski , et al. September 16, 2	2003-09-16
Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons Grant 6,620,787 - Jackowski , et al. September 16, 2	2003-09-16
Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons Grant 6,617,308 - Jackowski , et al. September 9, 2	2003-09-09
Method for retarding or precluding alzheimer's dementia App 20030152570 - Jackowski, George ; et al.	2003-08-14
Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons Grant 6,602,855 - Jackowski , et al. August 5, 2	2003-08-05
Biopolymer marker indicative of disease state having a molecular weight of 1020 daltons Grant 6,599,877 - Jackowski , et al. July 29, 2	2003-07-29
Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons Grant 6,593,298 - Jackowski , et al. July 15, 2	2003-07-15
Diagnosis and treatment of dementia utilizing thrombospondin App 20030119074 - Jackowski, George ; et al.	2003-06-26
Apolipoprotein biopolymer markers predictive of alzheimers disease App 20030113808 - Jackowski, George ; et al.	2003-06-19
Complement C3 precursor biopolymer markers predictive of Alzheimers disease App 20030100016 - Jackowski, George ; et al.	2003-05-29
Protein biopolymer markers indicative of age matched control App 20030100015 - Jackowski, George ; et al.	2003-05-29
Protein biopolymer markers predictive of insulin resistance App 20030100126 - Jackowski, George ; et al.	2003-05-29
HP biopolymer markers predictive of insulin resistance App 20030100013 - Jackowski, George ; et al.	2003-05-29
IG lambda biopolymer markers predictive of alzheimers disease App 20030100011 - Jackowski, George ; et al.	2003-05-29
Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance App 20030100009 - Jackowski, George ; et al.	2003-05-29
Plasma protease C1 biopolymer markers predictive of alzheimers disease App 20030100012 - Jackowski, George ; et al.	2003-05-29
Apolipoprotein biopolymer markers predictive of type II diabetes App 20030100014 - Jackowski, George ; et al.	2003-05-29
Fibrinogen biopolymer Marker predictive of type II diabetes App 20030100010 - Jackowski, George ; et al.	2003-05-29
Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance App 20030096431 - Jackowski, George ; et al.	2003-05-22
Process for differential diagnosis of Alzheimer's dementia in patients exhibiting mild cognitive impairment App 20030064416 - Jackowski, George ; et al.	2003-04-03
Diagnosis and treatment of early pre-type-1 diabetes utilizing glial fibrillary acidic protein App 20030054414 - Jackowski, George ; et al.	2003-03-20
Biopolymer marker indicative of disease state having a molecular weight of 1406 daltons App 20030040602 - Jackowski, George ; et al.	2003-02-27
Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein App 20030040660 - Jackowski, George ; et al.	2003-02-27
Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons App 20030013845 - Jackowski, George ; et al.	2003-01-16
Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons App 20030004307 - Jackowski, George ; et al.	2003-01-02
Method of treatment of alzheimer's disease and device therefor App 20020172676 - Jackowski, George ; et al.	2002-11-21
Process for differential diagnosis of Alzheimer's dementia and device therefor App 20020160425 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons App 20020160419 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1521 daltons App 20020160958 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1998 daltons App 20020160532 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons App 20020160417 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 2937 daltons App 20020161177 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons App 20020160422 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons App 20020160528 - Jackowski, George ; et al.	2002-10-31
Method for monitoring and validating stress induction of disease state App 20020160421 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons App 20020160529 - Jackowski, George ; et al.	2002-10-31
Process for diagnosis of physiological conditions by characterization of proteomic materials App 20020160420 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1777 daltons App 20020160434 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons App 20020161183 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1536 daltons App 20020160423 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons App 20020160531 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1949 daltons App 20020160418 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular of weight of 1525 daltons App 20020160533 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons App 20020161179 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons App 20020161187 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1896 daltons App 20020161180 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1020 daltons App 20020161188 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons App 20020161182 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons App 20020161185 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons App 20020161181 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons App 20020161184 - Jackowski, George ; et al.	2002-10-31
Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons App 20020161186 - Jackowski, George ; et al.	2002-10-31
Conjunctive analysis of biological marker expression for diagnosing organ failure Grant 6,461,828 - Stanton , et al. October 8, 2	2002-10-08
Method and apparatus for detection of multiple biological materials with a heterogeneous antibody mixture App 20020009811 - Bodenhamer, William T. ; et al.	2002-01-24
Method and device for diagnosing and distinguishing chest pain in early onset thereof Grant 5,747,274 - Jackowski May 5, 1	1998-05-05
Method and device for diagnosing and distinguishing chest pain in early onset thereof Grant 5,744,358 - Jackowski April 28, 1	1998-04-28
Method and device for diagnosing and distinguishing chest pain in early onset thereof Grant 5,710,008 - Jackowski January 20, 1	1998-01-20
Monoclonal antibody to human ventricular myosin light chains Grant 5,702,905 - Takahashi , et al. December 30, 1	1997-12-30
Method and device for diagnosing and distinguishing chest pain in early onset thereof Grant 5,604,105 - Jackowski * February 18, 1	1997-02-18
Monoclonal antibody to human cardiac myoglobin Grant 5,573,957 - Cardone , et al. November 12, 1	1996-11-12
Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof Grant 5,290,678 - Jackowski March 1, 1	1994-03-01